Ask AI
ProCE Banner Activity

Targeting PIK3CA/AKT/PTEN Alterations: Key Clinical Trials

Slideset

Downloadable slides on agents targeting PIK3CA/AKT/PTEN alterations in the treatment of patients with advanced breast cancer.

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Lilly and Stemline Therapeutics, Inc.

AstraZeneca

Lilly

Stemline Therapeutics, Inc.